Abstract
Propofol has a tumor-suppressive role in glioma, but the mechanism by which propofol is involved in glioma progression is largely unknown. This study aims to explore a potential circular RNAs (circRNAs)/microRNAs (miRNAs)/mRNA network in response to Propofol in glioma. Human glioma cell lines (U251 and LN229) were suffered from Propofol treatment (5 μg/mL for 24 h) and transfection. circRNA mitogen-activated protein kinase 4 (circMAPK4), miR-622, homeobox A9 (HOXA9) abundances were determined by quantitative reverse transcription polymerase chain reaction and western blot. Migration and invasion were analyzed via transwell analysis. Cell proliferation was evaluated using Cell Counting Kit-8 and colony formation analysis. Cell apoptosis and related protein expression were determined via flow cytometry and western blot. Target relationship was assessed via dual-luciferase reporter analysis, RNA pull-down and RNA immunoprecipitation. Propofol reduced circMAPK4 expression. Propofol inhibited cell proliferation, migration and invasion, while increased apoptosis via decreasing circMAPK4 in glioma cells. miR-622 was targeted via circMAPK4. circMAPK4 knockdown decreased glioma cell growth, migration and invasion by up-regulating miR-622. miR-622 knockdown reversed the effect of Propofol on glioma progression. HOXA9 was targeted by miR-622, and its expression was decreased by Propofol treatment. miR-622 overexpression restrained glioma progression via decreasing HOXA9. Propofol regulated circMAPK4/miR-622/HOXA9 axis in glioma cells. Propofol constrains glioma progression by regulating circMAPK4/miR-622/HOXA9 axis in vitro. Propofol restrains glioma cell growth, migration and invasion. circMAPK4 can regulate HOXA9 by sponging miR-622 in glioma cells. Propofol represses glioma progression via a circMAPK4/miR-622/HOXA9 axis.
Highlights
-
1.
Propofol restrains glioma cell growth, migration and invasion.
-
2.
circMAPK4 can regulate HOXA9 by sponging miR-622 in glioma cells.
-
3.
Propofol represses glioma progression via a circMAPK4/miR-622/HOXA9 axis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The analyzed data sets generated during the present study are available from the corresponding author on reasonable request.
References
Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, Merchant M, Pfister SM, Pollard SM, Ramaswamy V et al (2019) Challenges to curing primary brain tumours. Nat Rev Clin Oncol 16:509–520. https://doi.org/10.1038/s41571-019-0177-5
Ashrafizadeh M, Ahmadi Z, Farkhondeh T, Samarghandian S (2020) Anti-tumor activity of Propofol: a focus on MicroRNAs. Curr Cancer Drug Targets 20:104–114. https://doi.org/10.2174/1568009619666191023100046
Bhatlekar S, Fields JZ, Boman BM (2014) HOX genes and their role in the development of human cancers. J Mol Med (Berl) 92:811–823. https://doi.org/10.1007/s00109-014-1181-y
Di Vinci A, Casciano I, Marasco E, Banelli B, Ravetti GL, Borzi L, Brigati C, Forlani A, Dorcaratto A, Allemanni G, Zona G, Spaziante R, Gohlke H, Gardin G, Merlo DF, Mantovani V, Romani M (2012) Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome. J Cancer Res Clin Oncol 138:35–47. https://doi.org/10.1007/s00432-011-1070-5
Fan W, Zhu X, Wu L, Wu Z, Li D, Huang F, He H (2015) Propofol: an anesthetic possessing neuroprotective effects. Eur Rev Med Pharmacol Sci 19:1520–1529
Farooqi AA, Adylova A, Sabitaliyevich UY, Attar R, Sohail MI, Yilmaz S (2020) Recent updates on true potential of an anesthetic agent as a regulator of cell signaling pathways and non-coding RNAs in different cancers: focusing on the brighter side of propofol. Gene 737:144452. https://doi.org/10.1016/j.gene.2020.144452
He J, Huang Z, He M, Liao J, Zhang Q, Wang S, Xie L, Ouyang L, Koeffler HP, Yin D, Liu A (2020) Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas. Mol Cancer 19:17. https://doi.org/10.1186/s12943-019-1120-1
Lapointe S, Perry A, Butowski NA (2018) Primary brain tumours in adults. Lancet 392:432–446. https://doi.org/10.1016/S0140-6736(18)30990-5
Li F, Li F, Chen W (2020) Propofol inhibits cell proliferation, migration, and invasion via mir-410-3p/transforming growth factor-beta receptor type 2 (TGFBR2) Axis in glioma. Med Sci Monit 26:e919523. https://doi.org/10.12659/MSM.919523
Liu CA, Chang CY, Hsueh KW, Su HL, Chiou TW, Lin SZ, Harn HJ (2018) Migration/invasion of malignant gliomas and implications for therapeutic treatment. Int J Mol Sci 19. https://doi.org/10.3390/ijms19041115
Qin K, Tian G, Chen G, Zhou D, Tang K (2020) miR-647 inhibits glioma cell proliferation, colony formation and invasion by regulating HOXA9. J Gene Med 22:e3153. https://doi.org/10.1002/jgm.3153
Sahinovic MM, Struys M, Absalom AR (2018) Clinical pharmacokinetics and pharmacodynamics of Propofol. Clin Pharmacokinet 57:1539–1558. https://doi.org/10.1007/s40262-018-0672-3
Sanai N, Berger MS (2018) Surgical oncology for gliomas: the state of the art. Nat Rev Clin Oncol 15:112–125. https://doi.org/10.1038/nrclinonc.2017.171
Sekandarzad MW, van Zundert AAJ, Lirk PB, Doornebal CW, Hollmann MW (2017) Perioperative anesthesia care and tumor progression. Anesth Analg 124:1697–1708. https://doi.org/10.1213/ANE.0000000000001652
Song Q, Pang H, Qi L, Liang C, Wang T, Wang W, Li R (2019) Low microRNA-622 expression predicts poor prognosis and is associated with ZEB2 in glioma. Onco Targets Ther 12:7387–7397. https://doi.org/10.2147/OTT.S218161
Sun J, Li B, Shu C, Ma Q, Wang J (2020) Functions and clinical significance of circular RNAs in glioma. Mol Cancer 19:34. https://doi.org/10.1186/s12943-019-1121-0
Valdes-Rives SA, Casique-Aguirre D, German-Castelan L, Velasco-Velazquez MA, Gonzalez-Arenas A (2017) Apoptotic signaling pathways in glioblastoma and therapeutic implications. Biomed Res Int 2017:7403747. https://doi.org/10.1155/2017/7403747
Wang BC, Ma J (2015) Role of MicroRNAs in malignant glioma. Chin Med J 128:1238–1244. https://doi.org/10.4103/0366-6999.156141
Wang X, Xin Z, Xu Y, Ma J (2016) Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma. Tumour Biol 37:5963–5970. https://doi.org/10.1007/s13277-015-4455-2
Wang XY, Li YL, Wang HY, Zhu M, Guo D, Wang GL, Gao YT, Yang Z, Li T, Yang CY, Chen YM (2017) Propofol inhibits invasion and proliferation of C6 glioma cells by regulating the ca(2+) permeable AMPA receptor-system xc(−) pathway. Toxicol in Vitro 44:57–65. https://doi.org/10.1016/j.tiv.2017.06.026
Wang S, Yin Y, Liu S (2019) Roles of microRNAs during glioma tumorigenesis and progression. Histol Histopathol 34:213–222. https://doi.org/10.14670/HH-18-040
Wang D, Yang T, Liu J, Liu Y, Xing N, He J, Yang J, Ai Y (2020a) Propofol inhibits the migration and invasion of glioma cells by blocking the PI3K/AKT pathway through miR-206/ROCK1 Axis. Onco Targets Ther 13:361–370. https://doi.org/10.2147/OTT.S232601
Wang M, Suo L, Yang S, Zhang W (2020b) CircRNA 001372 reduces inflammation in Propofol-induced Neuroinflammation and neural apoptosis through PIK3CA/Akt/NF-kappaB by miRNA-148b-3p. J Invest Surg:1–11. https://doi.org/10.1080/08941939.2020.1771639
Wesseling P, Capper D (2018) WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol 44:139–150. https://doi.org/10.1111/nan.12432
Xavier-Magalhaes A, Goncalves CS, Fogli A, Lourenco T, Pojo M, Pereira B, Rocha M, Lopes MC, Crespo I, Rebelo O, Tao H, Lima J, Moreira R, Pinto AA, Jones C, Reis RM, Costello JF, Arnaud P, Sousa N, Costa BM (2018) The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma. Oncotarget 9:15740–15756. https://doi.org/10.18632/oncotarget.24597
Xu J, Xu W, Zhu J (2015) Propofol suppresses proliferation and invasion of glioma cells by upregulating microRNA-218 expression. Mol Med Rep 12:4815–4820. https://doi.org/10.3892/mmr.2015.4014
Xu J, Ma B, Chen G, Wei D, Li L, Hu W (2018a) MicroRNA-622 suppresses the proliferation of glioma cells by targeting YAP1. J Cell Biochem 119:2492–2500. https://doi.org/10.1002/jcb.26343
Xu W, Zheng J, Bie S, Kang L, Mao Q, Liu W, Guo J, Lu J, Xia R (2018b) Propofol inhibits Wnt signaling and exerts anticancer activity in glioma cells. Oncol Lett 16:402–408. https://doi.org/10.3892/ol.2018.8606
Xu Y, Pan S, Jiang W, Xue F, Zhu X (2020) Effects of propofol on the development of cancer in humans. Cell Prolif:e12867. https://doi.org/10.1111/cpr.12867
Zhang R, Luo H, Wang S, Chen Z, Hua L, Wang HW, Chen W, Yuan Y, Zhou X, Li D, Shen S, Jiang T, You Y, Liu N, Wang H (2015) MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells. J Neuro-Oncol 121:63–72. https://doi.org/10.1007/s11060-014-1607-y
Zhang Y, Lin X, Geng X, Shi L, Li Q, Liu F, Fang C, Wang H (2020) Advances in circular RNAs and their role in glioma (review). Int J Oncol 57:67–79. https://doi.org/10.3892/ijo.2020.5049
Zheng DH, Wang X, Lu LN, Chen DL, Chen JM, Lin FM, Xu XB (2018) MiR-638 serves as a tumor suppressor by targeting HOXA9 in glioma. Eur Rev Med Pharmacol Sci 22:7798–7806. https://doi.org/10.26355/eurrev_201811_16404
Author information
Authors and Affiliations
Contributions
Conceptualization and Methodology: Liuqiong Yu and Wenmin Tan; Formal analysis and Data curation: Hao Yang, Wensen Li and Rongzhou Xia; Validation and Investigation: Gaopeng Xiao and Liuqiong Yu; Writing - original draft preparation and Writing - review and editing: Gaopeng Xiao, Liuqiong Yu and Yujin Li; Approval of final manuscript: all authors.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
None.
Consent for publication
Patients agree to participate in this work.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xiao, G., Yu, L., Tan, W. et al. Propofol inhibits glioma progression by regulating circMAPK4/miR-622/HOXA9 axis. Metab Brain Dis 38, 233–244 (2023). https://doi.org/10.1007/s11011-022-01099-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-022-01099-x